Personalised Medicine and Novel Therapies MSc

Applicants should be: holders of a life science degree (2:1 or equivalent) or a recognised medical or dental degree (at 2.1 standard where a grade is required); or qualified medical practitioners, with a qualification equivalent to a UK MBBS, or healthcare, pharmaceutical or biotech professional and scientists with equivalent experience (minimum of three years).

The English language level for this programme is: Level 2.

Further information can be found on our English language requirements page.

Pre-Master's and Pre-sessional English

UCL Pre-Master's and Pre-sessional English courses are for international students who are aiming to study for a postgraduate degree at UCL. The courses will develop your academic English and academic skills required to succeed at postgraduate level.

Personalised medicine is the next generation of medicine and healthcare. It aims to improve the management of a patient's health and to target therapies to achieve the best outcomes in the management of a patient's condition, their predisposition to disease and their prognosis. Personalised healthcare takes a multi-omics approach (one which incorporates data from a range of different sources, including genomic and epigenomic) directed at the development of novel therapies.

This programme supports the training of our next generation of scientists to translate their knowledge in the field using genomic tools and therapeutic insights for clinical benefit.